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Abstract. Integrins are heterodimeric cell surface pro-
teins that mediate both cell-cell and cell-extracellular
matrix interactions. We and others recently identified
cDNAs encoding a novel integrin ß subunit, 07, in
lymphocytes. We have now detected 07 mRNA in
mouse TK-1 T lymphoma cells, which are known to
express the putative Peyer's patch homing receptor
a4ßP. We used an anti-peptide antiserum and a novel
mAb against the 07 subunit to show that TK-1 cells
express 07 as the only subunit associated with a4. We
conclude that 07 and ßP are identical. We also show
that activated peripheral blood T cells express a4ß7.
We studied the function of a4ß7/a4ßP in TK-1 cells,
which do not express very late antigen (VLA)-4 (a4ß1) .
Cells adhered to intact fibronectin and to a fibronectin
fragment containing the CS-1 region, but not to a
T
HE ability to interact with a variety of cells or with
proteins of the extracellular matrix is crucial for a
variety of leukocyte functions, including cell activa-
tion, phagocytosis, recruitment to sites of inflammation, re-
circulation, and homing (for reviews see Stoolman, 1989;
Butcher, 1990; Springer, 1990). Many adhesion molecules
expressed on T lymphocytes belong to the integrin family.
Integrins are noncovalently linked heterodimers consisting
of an a and a ß subunit that mediate cell-extracellular matrix
as well as cell-cell interactions (Hynes, 1987; Ruoslahti,
1991) . The a and ß subunits each have a large extracellular
domain, a short transmembrane region, and a cytoplasmic
tail. At least 13 different a and eight different ß subunits have
been identified to date; these combine to produce at least 18
different integrin heterodimers. Both a and ß subunits par-
ticipate in the determination ofligand specificity. The tripep-
tide RGD (Arg-Gly-Asp) is the recognition site for many of
the integrins that bind to extracellular matrix proteins.
Members of the 01 integrin subfamily (a1ß1 to a6ß1), also
referred to as the very late antigens (VLA-1 to VLA-6), bind
and mediate adhesion to several extracellular matrix proteins
such as laminin, collagens, and fibronectin (Hemler, 1990).
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fragment containing the RGD sequence. Adhesion to
fibronectin was inhibited by antibodies to a4, suggest-
ing that a4ß7 is a fibronectin receptor. We confirmed
that a4ß7 binds to the CS-1 region of fibronectin
using affinity chromatography. TK-1 cell adhesion to
the vascular cell adhesion molecule VCAM-1 was also
inhibited by antibodies to a4, implying that a4ß7 also
plays a role in the adherence of lymphocytes to endo-
thelial cells. TK-1 cell binding to fibronectin and
VCAM-1 is markedly increased by brief PMA stimula-
tion. We also found that mAbs against a4 and 07 in-
duce homotypic clustering of TK-1 cells. Taken to-
gether these results suggest that a4ß7/a4ßP recognizes
some or all of the same widely distributed ligands rec-
ognized by VLA-4 (a4ß1) and that the role of a4ß7/
a4ßP may not be restricted to lymphocyte homing.
a4ß1 (VLA-4) has been shown to be involved in at leastthree
different kinds ofadhesive interactions. First, a4ß1 mediates
cell adhesion to fibronectin by binding to the alternatively
spliced C9-1 region of fibronectin (Wayner et al., 1989;
Mould et al., 1990; Guan and Hynes, 1990). Second, a4ß1
mediates T cell adhesion to endothelium by binding to the
vascular cell adhesion molecule VCAM-1 (Elices et al .,
1990). T cell activation causes rapid enhancement of c4ß1-
mediated binding to both fibronectin and VCAM-1 (Shimizu
et al., 1990a,ó). Third, certain antibodies directed against
the a4 subunit of a4ß1 induce homotypic lymphocyte
clustering (Campanero et al., 1990 ; Bednarczyk and McIn-
tyre, 1990; Pulido et al., 1991) . This clustering is dependent
upon divalent cations. Clustering can be abolished by other
antibodies directed against a4 and by some anti-01 antibod-
ies, but not by antibodies against other integrins or VCAM-1.
It is possible that binding of anti-ce4 antibodies induces a
conformational change in a4ß1 that allows a4ß1 to bind to
an unidentified counterreceptor on adjacent cells. Alterna-
tively, binding of anti-c«4 antibodies might cause clustering
by triggering an a4ß1-mediated signal that activates other
adhesion pathways.
179In contrast to other integrin a subunits, the 150-kD a4
subunit can be cleaved ata site close tothe middle ofthe mol-
ecule, resulting in variable amounts of 80- and 70-kD a4
fragments (Sanchez-Madrid et al., 1986; Hemler et al.,
1987; Takada et al., 1989). Both the intact and the cleaved
forms of cA can associate with 01 on the cell surface to form
functionally active integrins. The relative expression of the
intact and cleaved forms greatly varies between different cell
lines and is affected by T cell activation.
In some murine lymphocytes, a4 can associate with a sec-
ond ß subunit, ßP (Holzmann et al., 1989; Holzmann and
Weissman, 1989) . The molecular cloning and sequence of
ßP has not yet been reported . Antibodies directed against
a4ßP block adhesion of lymphocytes to Peyer's patch high
endothelial venules (HEV)', but not peripheral lymph node
HEV, suggesting that a4ßP may be a Peyer's patch lympho-
cyte homing receptor. The ligand(s) of a4ßP have not been
previously identified.
We and others have recently reported the cloning and se-
quencing of cDNAs coding for a novel human integrin ß
subunit, 07, expressed in lymphocytes (Yuan et al., 1990;
Erle et al., 1991x). It has recently been shown that the 07
subunit is part of the murine M290 antigen complex (Kil-
shaw and Murant, 1990; Yuan et al., 1991) . M290 and its
putative human homolog HML-1 are highly expressed on
nearly all intraepithelial lymphocytes of the intestine (Cerf-
Bensussan et al ., 1987; Kilshaw and Murant, 1990). How-
ever, expression ofHML-1 was reported on peripheral blood
T cellsafter in vitro activation (Schieferdecker et al ., 1990).
The M290/HML-1 a subunits have not yet been identified,
but these subunits do not appear to be related to any of the
previously described a subunits. The functions of M290/
HML-1 remain to be determined.
We now report the detection of the 07 protein using a ß7-
specific antiserum and a mAb. We present evidence that a4
associates with 07 on mouse TK-1 lymphoma cells, that
a4ß7 and a4ßP are identical, and that a4ß7 is involved in
adhesion to fibronectin and VCAM-1 and in homotypic T cell
clustering. Our results also suggest that 07 can associate with
at least two different a subunits: a4 and an unidentified a
subunit that is part of the M290/HML-1 complex.
Materials andMethods
Cell Culture
The murineT cell lymphomaline TK-1 was kindly provided by Dr. I. Weiss-
man (Stanford University) (Holzmann et al ., 1989). Cells were grown at
37°C, 5% COZ, and 100% humidity in RPMI 1640 medium (Cell Culture
Facility, University of California, San Francisco, CA) supplemented with
10% FCS (HyClone Laboratories Inc., Logan, UT). Human peripheral
blood T cells were purified as previously described (Erie et al., 1991x) .
Purified T cells (1 x 106 cells/ml in RPMI 1640 medium and 10% FCS)
were activated by incubationwith the anti-CD3 mAb TR66 (1 ug/ml, kindly
provided by Dr. S. Abrignani, CIBA-GEIGY, Basel, Switzerland) for 20
min at 4°C, washing, and incubation with goat-anti-mouse IgG antiserum
(1:500) (Boehringer Mannheim Corp., Indianapolis, IN) for 20 min at 4°C.
After 48 h, human recombinant interleukin-2 (20 U/ml, Boehringer-
Mannheim Corp.) was added to the cultures.
1. Abbreviations used in this paper: HEV, high endothelial venules; PCR,
polymerase chain reaction.
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RNA Extraction, cDNASynthesis, HomologyPCR,
andNorthern Blotting Analysis
Total RNA extraction, cDNA synthesis, and homology polymerase chain
reaction (PCR) amplification of integrin ß subunits was performed as previ-
ously described (Erle et al., 1991b) . Briefly, total RNA was prepared from
TK-1 cells using the LiCl-urea method and reverse transcribed to cDNA.
Integrin ß subunit partial cDNAs were amplified using the primer mixtures
BIAF and B2AR that recognize two regions that are conserved in all known
0 subunit sequences (Erle et al., 1991b). Amplified cDNAs were cloned
(using the pBluescript plasmid) and sequenced. RNA gel electrophoresis
and Northern blottinganalysis were performed as previously described with
a probe made from a partial 07 cDNA clone containing nucleotides
857-2761 of the ß7 cDNA using the random primer method (Erie et al.,
1991x).
AntiseraandAntibodies
A peptide modeled after the carboxyl-terminal sequence of 07 (Erle et al.,
1991x) plus an amino-terminal cysteine (CQDSNPLYKSAITTTINPRF-
QAEDSPTL, kindly provided by Dr. L. Reichardt, University of Califor-
nia, San Francisco, CA) was coupled to keyhole limpet hemocyanin (Cal-
biochem Corp., San Diego, CA) using m-Maleimidobenzoyl-N-hydroxy-
sulfosuccinimide (Pierce Chemical Co., Rockford, IL) and glutaraldehyde
(Fisher Scientific Co., Pittsburgh, PA) (Harlow andLane, 1988). A 1:1 mix-
ture ofthe two conjugates was used to immunize a rabbit (CALTAG Labora-
tories, South San Francisco, CA). The antiserum was affinity purifiedusing
the same peptide coupled to Sepharose. Antisera against other integrin
subunits were also obtained by immunizing rabbits with peptides modeled
after the carboxyl termini and were generously provided to us by other
investigators (a4 antiserum, Drs. M. Johannson and E. Ruoslahti, La
Jolla Cancer Research Foundation (La Jolla, CA); /31 antiserum, Dr. L.
Reichardt; ß2 antiserum, Dr. E. Small, University of California, San
Francisco, CA).
The mAb LS722 was obtained by immunizing a rat with supernatants
from chymotrypsin-treatedmesenteric lymphocytes andboosting with TK-1
cells (Sikorski, E. E., and E. C. Butcher, manuscript in preparation). Hy-
bridomas were selected by testing culture supernatant for their ability to
specifically stain TK-1 cells but not thymocytes. Rat anti-mouse a4 mAbs
were generous gifts of Dr. I. Weissman (Rl-2) (Holzmann et al., 1989) and
Dr. P. Kincade (Oklahoma Medical Research Foundation, Oklahoma City,
OK) (PS/2) (Miyake et al., 1991b). The mAb M290 was a generous gift
of Dr. S. Mutant and Dr. P. Kilshaw (Institute for Animal Physiology and
Genetic Research, Babraham, Cambridge) (Kilshaw and Murant, 1990).
The rat anti-mouse hybridoma FD441, anti-LFA1 a subunit, was ob-
tained from theAmerican Type Culture Collection (Rockville, MD) (ATCC
TIB213) (Sarmiento et al., 1982). This mAb was purified and concentrated
from culture supernatant by ammonium sulfate precipitation. The rat mAb
KM201, anti-murine Pgp-1/CD44, was a generous gift of Dr. P. Kincade
(Miyake et al., 1990). The anti-human a4 mAb P4G9 was purchased from
Telios Pharmaceuticals Inc., (San Diego, CA) (Wayner et al., 1989). mAb
against human and murine VCAM-1 were kindly provided by Dr. J. Harlan
(University ofWashington, Seattle, WA) (4B9) (Carlos et al., 1990) and by
Dr. P. Kincade (M/K-1) (Miyake et al., 1991b).
Immunoprecipitation Experiments
Cells were surface labeled with I'll (for TK-1 cells) or biotin (for human
T cells) . For "'I labeling, 20-200 x 106 TK-1 cells were washed and
resuspended in 1 ml PBS, 0.1 ml 1% o-glucose, 0.1 ml enzymobeads suspen-
sion (Glucose oxidase/lactoperoxidase, BioRad Laboratories, Richmond,
CA) and 1-2 mCi Na125I (DuPont/New England Nuclear, Boston, MA or
Amersham Corp., Arlington Heights, IL). Cells were labeled for 20 min
at room temperature under continuous gentle agitation and washed once in
PBS. For biotin labeling, T cells were resuspended in 5 ml PBS containing
0.2 mg/ml N-hydroxysulfosuccinimide-biotin, (Pierce Chemical Co.) and
incubated for 20 min on ice. Before lysis cells were washed twice in PBS
in the presence of 25 mM t.-lysine. After "I or biotin labeling, cells were
lysed on ice in 1 ml immunoprecipitation buffer (100 mM Tris, pH 7.4, 150
mM NaCI, 1 mM CaCIZ, 1% Triton X-100, 0.1% SDS, 0.1% NP-40) sup-
plemented with 1 WM PMSF (GIBCO-BRL, Life Technologies, Gaithers-
burg, MD), 1 ug/mL Pepstatin and 1 ug/ml Leupeptin (Boehringer Mann-
heim Corp.). Cell lysates were precleared with protein A-Sepharose (Phar-
macia-LKB Biotechnology, Piscataway, NJ) and incubated with antibodies
at 4°C for 1 h. Rabbit anti-rat IgG antiserum (Zymed Laboratories Inc.,
San Francisco, CA) was added whenevera rat mAb was used. Immunecom-
180plexes were captured on protein A-Sepharose, washed, dissolved in
Laemmli sample buffer, and analyzed by SDS-PAGE (7.5% acrylamide)
(Laemmli, 1970). To detect biotinylated antigen, proteins were transferred
from the gel onto a nylon membrane (Immobilon; Millipore Corp., Bed-
ford, MA). The membrane was blocked with 3% BSA (Fisher Scientific
Co.) and 2.5% nonfat dry milk (Carnation, Los Angeles, CA) in PBS for
4-16 h at room temperature, incubated in 0.2-1 pg/ml streptavidin-HRP
(Pierce Chemical Co.) in washing buffer (PBS/0.5% BSA/0.1% Tween 20)
for 20 min, washed 5 times in washing buffer, incubated in ECL solution
(Amersham Corp.) for 1 min, immediately wrapped in plastic, and exposed
to film.
In immunodepletion experiments, the antigen of interest was removed
from the lysate by two cycles of immunoprecipitation using a large excess
of antiserum or mAb and Protein A-Sepharose. Residual proteins were
precipitated from the depleted lysates as described above. For EDTA dis-
sociation experiments, washed protein A-Sepharose antibody-antigen com-
plexes were incubated in 20 mM EDTA, 50 mM TRIS, pH 7.4, and 0.1%
SDS for 10 min. Supernatants containing released subunits were collected
and analyzed by SDS-PAGE. Material that remained bound to protein
A-Sepharose was solubilized in Laemmli's sample buffer and analyzed by
SDS-PAGE.
AdhesionAssays
For adhesion assays, 96-well Linbro plates (Flow Laboratories Inc.,
McLean, VA) were coated for 2-16 h at 4°C with 50 Al of the following
proteins dissolved in 100 mM NaHC03: rat collagen I (Sigma Chemical
Co., St. Louis, MO); plasma fibronectin and vitronectin (purified from hu-
man plasma according the methods of Engvall and Ruoslahti [1977] and
Yatohgo et al. [1988] and generously provided by Dr. M. Busk, University
of California, San Francisco, CA); a 120-kD fibronectin fragment contain-
ing the RGD sequence (Telins Pharmaceuticals Inc.), a 38-kD fibronectin
fragment containing the CS-1 sequence (donated by Dr. A. Garcia-Pardo,
Centro de Investigaciones Biologicas, Madrid, Spain) (Garcia-Pardo et al.,
1990) and recombinant soluble human VCAM-I (kindly provided by Dr. R.
Lobb, Biogen Inc., Cambridge, MA) (Lobb et al., 1991). Plates were
blocked with 1 % BSA for 2 h at 37°C. In some experiments TK-1 cells were
labeled with BCECF (2,7,-bis-[2-carboxyethyl]-5[6]-carboxy-fluorescein ;
Sigma Chemical Co.) and/or stimulated with PMA (50-100 ng/ml). TK-1
cells were added to the plates and allowed to adhere for 15 min to 2 h in
a 37°C, 5% C02 incubator. In inhibition experiments, TK-1 cells were
preincubated for 30 min in the presence of mAbs or synthetic peptides be-
fore plating. The CS-1 peptide (KKTDELPQLVTLPHPNLHGPEILDVP-
STVQK) (Mould et al ., 1990) and a control peptide (CKSILQEENRRD-
SWSYINSKSNDD) were synthesized in our laboratory. Nonadherent cells
were removed by washing the plates (Pulido et al., 1991) or by inverse cen-
trifugation (Charo et al., 1985). In experiments where BCECF-labeled cells
were used, adherent cells were lysed and quantified by fluorimetry. In ex-
periments where unlabeled cellswere used, adherent cells were counted un-
der a microscope or by crystal violet staining and determination of absor-
bance using a plate reader. All assays were performed at least in duplicate.
Affinity Chromatography
Affinity chromatography was performed as previously described (Pytela et
al., 1987). CS-1 peptide (see above) and a control peptide (ß7 carboxyl ter-
minus peptide, see above) were coupled to CNBr-activated Sepharose-4B
(Sigma Chemical Co.) following the manufacturer's instructions (7 mg pep-
tide/g Sepharose). 1-2 x 10' TK-1 cells were stimulated for 300 min with
PMA (100 ng/ml), labeled with I'll as above and lysed in affinity chroma-
tography buffer (Tris 50 mM, pH 7.4, NaCl 150 mM, CaC12 2 mM,
MnC12 1 mM) supplemented with 100 mM n-octylglucoside (Boehringer-
Mannheim Corp.) and 10 mg/ml BSA (Fisher Scientific). Lysates were
precleared with underivatized Sepharose 4B and applied to the columns at
4°C. Columns were washed with 5 vol affinity chromatography buffer con-
taining 25 mM n-octyl-glucoside. Specifically bound proteins were eluted
with EDTA (Tris 50 mM, pH 7.4, NaCl 150 mM, EDTA 10 mM). Aliquots
ofthe fractions were analyzedbySDS-PAGE . Fractionsofinterest were dia-
lyzed against immunoprecipitation buffer and analyzed in immunoprecipi-
tation experiments.
CellClusteringAssay
TK-1 cells were washed twice in PBS and resuspended in RPMI 1640
medium supplemented with 10% FCS. 5 x l0° cells in 100 Al were plated
in 96-well tissue culture plates in the presence of different mAbs and in-
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cubated at 37°C. Cultures were observed under the microscope and cluster-
ing was scored using a modification of the system of Rothlein and Springer
(1986): 0 indicated that no cells were aggregated; 1+ indicated up to 20%
ofthe cells were in aggregates; 2+, 20-40% ; 3+, 40-60% ; 4+, 60-80%;
and 5+, 80-100% . All assays were performed in duplicate.
Flow Cytometry
Unstimulated TK-1 cells or TK-1 cells incubated for 30 min in the presence
of 100 ng/ml PMA were collected, washed twice, and resuspended in PBS
at 2 x 106 cells/ml. Saturating amounts of mAbs were added to the cells.
After a 20-min incubation at 4°C, cells were washed and resuspended in
PBS. Phycoerythrin-labeled rabbit anti-rat IgG (H+L) F(ab)' (Zymed
Laboratories Inc.) was added and the cells were incubated for 20 min at
4°C. After washing, cells were fixed (Coulter Immunology, Hialeah, FL)
and analyzed with a flow cytometer (FACScan; Laboratory for Cell Analy-
sis, University of California, San Francisco, CA).
Results
TK-1 Cells Express ß7mRNA
We used the homology PCR technique (Erle et al., 1991b)
to identify integrin ß subunit cDNAs from TK-l cells, which
are known to express the ßP subunit (Holzmann and Weiss-
man, 1989). This technique relies upon the use of oligonu-
cleotide primer mixtures designed to recognize all known
integrin ß subunit cDNAs. We obtained 20 partial integrin
ß subunit cDNA clones from TK-1 cells. The sequence ob-
tained from 15 of these clones is very similar to the human
/37 sequence (96% identity of deduced amino acid se-
quences), and presumably represents mouse 07 (see Discus-
sion) . This sequence is identical to the sequences of 07
clones previously obtained from two other mouse cell lines
(Erle et al., 1991b). The sequence obtained from the five
other TK-1 cell cDNA clones is identical to the previously
reported mouse 02 sequence (Koffer, 1991). In TK-1 cells,
unlike other cells we have previously studied using homol-
ogy PCR (Erle et al., 1991b), no /31 cDNA clones were ob-
tained. This is consistent with a previous report that ßl
mRNA is not detectable in TK-1 cells using Northern blot-
ting (Holzmann and Weissman, 1989) . We were able to de-
tect 07 mRNA of rv3.2 kb in size in TK-1 cells using North-
ern blotting (data not shown). Since only 07 and 02 cDNA
clones were obtained from TK-1 cells, we hypothesized that
07 and ßP might be identical.
07Associates with a4 on TK-1 Cells
We raised an antiserum against the integrin 07 subunit by
immunizing a rabbit with a peptide containing the 27 car-
boxyl-terminal residues of the deduced human 07 amino
acid sequence. SDS-PAGE analysis of material immunopre-
cipitated from surface-labeled TK-1 cells with the anti-ß7
antiserum revealed four protein bands at -150, 120, 80, and
70 kD under nonreducing conditions (Fig. 1). A similar pat-
tern of bands was obtained using two antibodies against the
a4 subunit: the mAb RI-2 and a polyclonal antiserum directed
against the carboxyl terminus of c«4. The novel mAb LS722,
raised against mesenteric lymphocytes, also produced four
similar bands. Based on previous data concerning a4-con-
taining integrins (Hemler et al., 1987), we provisionally
identified the 150-kD band as the uncleaved a4 subunit, the
120-kD band as the 07 subunit, and the 80- and 70-kD com-
ponents as the fragments resulting from the cleavage of a4 .
No material was precipitated using anti-ßl antibody, con-firming that TK-1 cellsdo not express 01 integrins. Analysis
of the material immunoprecipitated with an anti-ß2 antise-
rum revealed two radiolabeled bands at -170 and 95 kD,
consistent with the known molecular masses of the aL and
02 subunits of LFA-1 . The anti-ß7 antiserum does not cross
reactwith 02 despite the similarity between thecarboxyl ter-
mini of these two molecules. Under reducing conditions the
putative 07 subunit comigrated with the intact a4 subunit .
Integrin ß subunits, which have many intrachain disulfide
bonds, typically migrate more slowly after reduction .
We used immunodepletion to demonstrate that antibodies
Figure 1 . Immunoprecipitation of inte-
grin complexes from TK-1 cells. mAbs
Rl-2 (directed against the a4 subunit)
andLS722 (722)and polyclonal antisera
raised against peptides modeled after
the carboxyl termini of the a4, 07, 01,
and 02 subunits were used to immuno-
precipitate proteins from 1251 surface-
labeled TK-1 mouse T lymphoma cells .
TK-1 cells were incubated with PMA
100 ng/ml for 30 min at 37°C before
labeling. Immunoprecipitates were re-
leased from protein A-Sepharose with
Laemmli's sample buffer and analyzed
using nonreducing and reducing SDS-
PAGE, as indicated . Relative molecular
masses (in kD), position of molecular
weight markers, positions of the intact
a4 subunit (a415°), the 07 subunit, and
the cleaved a4 subunit fragments (a480
and cr4'~ are indicated . Similar results
were obtained when unstimulated TK-1
cells were used for immunoprecipitation
(data not shown) .
toa4 and07 and themAb LS722 allrecognize the same anti-
gen complex on TK-1 cells (Fig . 2 A) . TK-1 lysate was im-
munodepleted usingantibodies againsta4 (RI-2) and 07 (an-
tipeptide antiserum) and themAbLS722 . ThemAbFD441,
which recognizes the unrelated integrin LFA-1 (oeL02), was
used as a control . Remaining antigen was then immunopre-
cipitated from the depleted lysates usingeach of the four an-
tibodies . We found that the anti-a4 antibody RI-2 depleted
all07 antigen from the lysate, and the07 antiserum depleted
all a4 antigen . This demonstrates that a4 and 07 are as-
sociated . We also found that mAb LS722 depleted both a4
Figure 2 . Analysis of a4ß7 by immunodepletion and EDTA-induced dissociation . (A) Immunodepletion analysis of integrins expressed
onTM cells . Equal aliquots ofa lysate made from surface-labeled TK-1 cellswere immunodepleted usingmAbRl-2 (anti-a4), the anti-ß7
antiserum, mAb LS722, and mAb FD441 (anti-LFA1 a subunit) . Remaining antigen was then immunoprecipitated with the same four
antibodies and analyzed by nonreducingSDS-PAGE . (B) EDTA-induced dissociation of immunoprecipitated complexes . An anti-a4 antise-
rum, the07 anti-peptide antiserum, andmAbLS722 were used to immunoprecipitate protein complexesfromTM cells. Immunoprecipi-
tated complexes (still bound to protein A-Sepharose) were dissociated with 20 mM EDTA and soluble proteins were collected (lane 1) .
Proteins that had not been released were then solubilized in Laemmli's sample buffer (lane 2) . Proteins were analyzed by nonreducing
SDS-PAGE .
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￿
182Figure 3 . Analysis of07mRNA and pro-
tein expression in peripheral blood T
cells . (A) 07 mRNA level increases after
T cell activation . Total RNA (15 lAg/
lane) was obtained from human periph-
eral blood T cells before (day 0) and 1,
3, and 14 d after activation by T cell
receptor complex crosslinking (see Ma-
terials and Methods) . /37 mRNA was
detected by Northern blotting hybrid-
ization with a 32plabeled probe made
using a 1,905-nucleotide fragment of 07
cDNA . Positions of the 28S and 18S
ribosomal RNA bands are indicated at
the left . Ethidium bromide staining was
used to verify that similar amounts ofto-
tal RNA were loaded in each lane. (B)
Immunoprecipitation of ß7-containing
integrins from activatedT cells . 14 d af
ter activation, T cells were surface labeled using sulfo-NHS-biotin . Antibodies against a4 (P4G9) and 07, 01, and 02 (anti-peptide antisera)
were used for immunoprecipitation . Immunoprecipitated proteins were analyzed by reducing SDS-PAGE . The biotinylation procedure
results in an artifactual band migrating at -65-70 kD, near the 70-kD a4 fragment .
and 07, while antibodies to a4 and 07 depleted the LS722
antigen . This demonstrates that mAb LS722 recognizes the
a4ß7 complex .
We used a modification of the immunoprecipitation pro-
tocol to show that mAb LS722 recognizes the 07 subunit of
the a4ß7 complex . Antisera against a4 and 07 and mAb
LS722 were used for immunoprecipitation . After washing,
the protein A-Sepharose antibody-antigen complexes were
incubated with EDTA, which has previously been shown to
dissociate a4 from ßP (Holzmann and Weissman, 1989) .
When the anti-c«4 antiserum was used, the 120-kD 07
subunit was released from the complex by EDTA (Fig. 2 B,
anti-a4, lane 1) . When the anti-ß7 antiserum and the mAb
LS722 were used, EDTA treatment released the 150-, 80-,
and 70-kD a4 subunits (anti-ß7and 722, lanes 1) . This con-
firms that the anti-ß7 antiserum and the mAb LS722 both
recognize the 120-kD 07 protein of the complex .
ß7 Expressionon In VitroActivatedHuman
Peripheral TCells
We previously described the activation-dependent induction
of 07 mRNA inhuman peripheral T lymphocytes after stim-
ulation with ionomycin and PMA (Erie et al ., 1991x) . Here
we activated T cells via the T cell receptor-CD3 complex
using cross-linked anti-CD3mAb and studied 07mRNA and
protein expression . Northern blot analysis was performed on
total RNA extracted from purified human peripheral blood
T cells before activation (d 0) and 1, 3, or 14 d after activation
(Fig . 3 A) . 07 mRNA was undetectable at 0, 1, and 3 d but
was present 14 d after activation .
We used the anti-ß7 antiserum to analyze the expression
of ß7-containing integrins on T cells 14 d after activation
(Fig . 3 B) . Antibodies to a4 (P4G9), and 07, ßl, and 02
(anti-peptide antisera) were used for immunoprecipitation.
The anti-/37 antiserum immunoprecipitates proteins of -150,
140, 80, and 70 kD (reducing conditions) . The 80- and
70-kD bands are very likely to represent the cleaved form
ofa4 since no other known integrin a subunit is cleaved to
produce fragments of these sizes . The results suggest that in-
tact or cleaved a4 can associate with either 01 or 07 in acti-
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vatedT cells . It appears that a4ß7 is the major ß7-containing
integrin in these cells . However, these results do not exclude
the presence of other ß7-containing integrins on activated
T cells (see Discussion) .
a4ß7 Mediates TK-1 CellAdhesion to Fibronectin
We used TK-1 cells to examine possible interactions between
a4ß7 and extracellular matrix proteins . Neither unstimu-
lated nor PMA-stimulated TK-1 cells adhered to vitronectin,
collagen I, collagen IV, laminin, fibrinogen, or the RGD-
containing 120-kD fibronectin fragment (Fig . 4 and data not
shown) . In contrast, PMA-stimulated TK-1 cells did adhere
to intact fibronectin . PMA stimulation had a marked effect
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Figure 4. Adherence of unstimulated and PMAstimulated TK-1
cells to intact fibronectin, the 120-kD chymotryptic fragment of
fibronectin (FN 120), vitronectin, and collagen I . 96-well plates
were coated with matrix proteins (0, 0.1, 0.3, or 1.01g/well) and
then blocked with BSA . BCECF-labeled TK-1 cells were allowed
to adhere for 2 h in the absence (- - - -) or presence ( )
ofPMA (100 ng/ml) and nonadherent cells were removed by cen-
trifugation of the inverted plate . Adherence was measured by
fluorimetry .Figure 5. Inhibition of TK-1
cell adherence to fibronectin
by antibodies to a4 and by a
CS-1 peptide. (A) Antibodies
to cA specifically inhibit ad-
herence of TK-1 cells to the
mAb
￿
38-kD tryptic fragment of
fibronectin . Unlabeled TK-1
cells were preincubated with
mAb against the LFA-1 a
subunit (FD441, 5 ug/nf), the
a4 subunit (PS/2, 1:10 dilu-
tion of supernatant or RI-2,
5 ug/ml), or the 07 subunit
(722, 5 jg/ml) . Cells were al-
lowed to adhere to the 38-kD fibronectin fragment (0.5 Ag/well) for
30 min at 37°C in the absence (o) or presence (m) of PMA (50
ng/ml) . Non-adherent cells were removed by gentle washing . Ad-
herent cells were counted under a microscope. Adherence to wells
treated withBSA alone is shown for comparison . (B) CS-1 peptide
blocks adherence ofPMA-stimulated TK-1 cells to intact fibronec-
tin . TK-1 cells were allowed to adhere to fibronectin (1.0 pg/well)
in the presence ofPMA (100 ng/ml) and up to 0.8 mg/ml of CS-1
peptide or control peptide (see Materials and Methods) . Nonad-
herent cells were removed by washing and adherent cells were
fixed and stained with crystal violet . Adherence was measured by
absorbance (adherence of cells in the absence of peptide is defined
as 100%) .
BBA
Controlpeptido
0.2 0.4 0.8
m g/ft
on adhesion to fibronectin ; this effect was apparent within 15
min and maximal at -30 min (data not shown) .
To investigate whether the alternative cell attachment do-
main CS-1 was involved in the observed binding to fibronec-
tin, we studied the adhesion ofTK-1 cells to the 38-kD tryp-
tic fragment of fibronectin, which contains the CS-1 domain
(Fig . 5 A) . This attachment was mediated by an a4-contain-
ing integrin since it was blocked by the anti-a4 mAbs RI-2
and PS/2 . These antibodies also blocked attachment to intact
fibronectin (data not shown) . The anti-ß7 mAb LS722 had
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no effect on binding to fibronectin . This suggests that LS722
recognizes a 07 epitope not involved in fibronectin binding .
Control antibodies had no effect on adhesion of TK-1 cells
to fibronectin (Fig . 5 A and data not shown) . We also inves-
tigated the adhesion of PMA-stimulated TK-1 cells to intact
fibronectin in the presence ofa blocking peptide modeled af-
ter the CS-1 region of fibronectin (Fig . 5 B) . This peptide
had a dose-dependent inhibitory effect on the adhesion of
PMA-stimulated TK-1 cells to fibronectin (40% inhibition at
0.8 mg/ml) .
a4ß7 Binds to theImmobilizedCS-1 Aeptide
inA ffinity Chromatography
We used affinity chromatography to determine whether
a4ß7 binds to the CS-1 region of fibronectin, as suggested
by the TK-1 adhesion experiments. Lysates from PMA-stim-
ulated and surface-labeled TK-1 cells were applied to CS-1
peptide and control peptide columns . After washing, spe-
cifically bound material was eluted with EDTA . Wash frac-
tions and EDTA-eluted fractions were analyzed by SDS-
PAGE (Fig . 6 A) . Proteins of -150, 120, 80, 70, and 55 kD
were present in decreasing amounts in successive wash frac-
tions and dramatically increased with EDTA elution . An
additional unidentified protein of -190 kD was eluted by
EDTA . EDTA-eluted material from the CS-1 peptide and
control peptide columns was analyzed by immunoprecipita-
tion (Fig. 6 B) . a4ß7, but not the 190-kD protein, was im-
munoprecipitated from the CS-1 eluate using antisera against
a4 and 07. In contrast, these antibodies did not immunopre-
cipitate any detectable material from eluates of a column
made with a control peptide . These data show that a4ß7
specifically binds to the CS-1 peptide .
a4ß7 Mediates Adhesion ofTK1 Cells
to Purified VCAM1
The endothelial cell surface protein VCAM-1 is a ligand
184
Figure 6. CS-1 peptide affinity
chromatography. (A) SDS-
PAGE analysis of fractions
from a CS-1 peptide column .
PMA stimulated TK-1 cells
were surface labeled with 1251
and lysed in n-octyl-gluco-
side-containing buffer. The
lysate was applied to a CS-1
peptide column . The column
was washed with wash buffer
(fractions 1-12) followed by
EDTA elution (fractions 13-
16) . (B) Immunoprecipitation
of proteins eluted from CS-1
and control peptide columns .
a4 and 07 anti-peptide anti-
sera were used to immunopre-
cipitate a4ß7 from the TK-1
total lysate and from EDTA-
eluted fractions from CS-1
and control peptide columns.
Column fractions and immu-
noprecipitates were analyzed
by nonreducing SDS-PAGE .100 -
80
60 -
40-
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for the c«4-containing integrin a4ß1. To determine whether
a4ß7 might also bind VCAM-1 we studied TK-1 cell ad-
hesion to recombinant soluble human VCAM-1, which is
similar to mouse VCAM-1 (Miyake et al., 1991x) . There
was minimal or no binding of unstimulated TK-1 cells to
VCAM-1. After PMA stimulation, there was essentially com-
plete cell binding to VCAM-1 (Fig. 7). The binding was a4
dependent since the adhesion was completely inhibited by ei-
ther of the two anti-a4 mAbs (RI-2 or PS/2) . The anti-
VCAM-1 mAb 4B9 also completely inhibited TK-1 adhesion
to VCAM-1 . The anti-ß7 mAb LS722 had no effect, suggest-
ing that the epitope recognized by LS722 is not involved in
binding to VCAM-1. Antibodiesto other adhesion molecules
(LFA-1, Pgp-1/CD44, leukocyte common antigen) had no
effect on TK-1 cell adhesion to VCAM-1 (Fig. 7 and data not
shown). These results strongly suggest that VCAM-1 is a
ligand for a4ß7.
rnAbsAgainsta4 and07Induce Clustering
ofTK1 Cells
a4ß1 is involved in homotypic cell clustering. a4ß1-medi-
ated T cell clustering can be triggered by mAbs against par-
ticular epitopes on the a4 subunit (Bednarczyk and McIn-
tyre, 1990; Campanero et al., 1990 ; Pulido et al., 1991). To
study whether a4ß7 may also be involved in homotypic
T cell clustering we incubated TK-1 cells in the presence of
mAbs against a4 (PS/2 and RI-2) and 07 (722) (Table I and
Fig. 8) . Clustering was detectable by 2 h and became more
pronounced at later time points. Control antibodies recog-
nizing other cell-surface molecules did not induce cluster-
ing. Addition of EDTA completely abolished antibody-in-
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None FD441 PS/2 R1-2 722 4B9
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Figure 7 . Antibodies to a4 inhibit adherenceofPMAstimulatedTK-1 cells to VCAM-1. 96-well plates werecoated with recombinant soluble
human VCAM-1 (0.5 jig/well) and blocked with BSA. Unlabeled TK-1 cells were preincubated with mAb against the LFA-1 a subunit
(FD441, 5 ttg/ml), the a4 subunit (PS/2, 1:10 dilution of supernatant or RI-2, 5 ug/ml), or the 07 subunit (722, 5 /.g/ml). To determine
the effect of the antibody to VCAM-1, wells were preincubated with 10 pg/ml of the mAb 4B9. Cells were allowed to adhere for 30 min
at 37°C in the absence (o) or presence (m) of PMA (50 ng/ml). Adherent cells were counted under a microscope.
duced TK-1 cell clustering (data not shown) . The TK-1 cell
clustering induced by RI-2, PS/2 or LS722 was not inhibited
by preincubation with mAbs against LFA-1 (FD441) or
VCAM-1 (M/K-1), demonstrating that the observed effects
were LFA-1 and VCAM-1 independent (data not shown).
TK1 CellsExpress HighLevels ofa4and07butLittle
orNo M290Antigen byFlow Cytotnetry
We used flow cytometry to detect adhesion molecules on
TK-1 cells and to determine whether PMA stimulation had
an effect on a4ß7 expression (Fig. 9) . Both a4 (RI-2 and
PS12 mAbs) and 07 (722) are detectable by flow cytometry.
While brief (30 min) PMA stimulation has a dramatic effect
on a4ß7 function (Figs. 4, 5, and 7), it has no detectable
TableI. AggregationofTK-1 Cells bymAbs against
a4andß7*
' Aggregation of TK-1 cells at 37°C in the presence of mAb (1 Wg/ml of
purified antibody or 1:10 dilution of PS/2 hybridoma supernatant). Theextent
of aggregation was estimated as described in Materials and Methods.
mAb Specificity Incubation time
30 min 3 h 8 h 11 h
None - 0 0 0 0
R1-2 a4 subunit 0 ++ ++++ +++++
PS/2 a4 subunit 0 + + ++ + ++ +
722 07 subunit 0 +++ ++++ +++++
FD441 aL subunit 0 0 0 0
M/K-1 VCAM-1 0 0 0 0
KM201 Pgp-1/CD44 0 0 0 0Figure 8. Antibody-induced TK-1 cell clustering . TK-1 cells (5 x
10° cells in 100 A,1) were incubated in the absence of antibody (-)
or in the presence ofmAb (1 Ag/ml) against (37 (722) or a4 (RI-2) .
Cells were photographed after 8 h of incubation . Bar, 500 I,m .
effect on the amount ofa4ß7 expressed on the cell surface .
Although the M290 antigen complex is known to include the
07 subunit (Kilshaw and Mutant, 1990; Yuan et al ., 1991),
little or no M290 antigen is detectable on these cells . This
result implies that M290 does not recognize a4ß7. Consid-
ered in the light ofprevious reports about the structure ofthe
M290 antigen complex, our findings suggest that 07 can as-
sociate with multiplea subunits . In TIC 1 cells, 07 associates
only with a4 . In M290+ intraepithelial lymphocytes, 07 ap-
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parently associates with one or more as yet unidentified a
subunits to form the M290 antigen complex .
Discussion
We and others previously identified the integrin 07 subunit
cDNA from human lymphocytes using homology PCR (Yuan
et al ., 1990 ; Erle et al ., 1991x) . The work presented here
began as an effort to identify the 07 protein . We were partic-
ularly interested in determining the relationship between 07
and the lymphocyte integrin subunit ßP, identified by immu-
nological techniques (Holzmann and Weissman, 1989) . We
chose to study mouse TK-1 T lymphoma cells because these
cells are known to express ßP Using homology PCR, we
identified one cDNA encoding mouse 02, and a second
cDNA encoding a portion ofamouse ß subunit that is 96%
identical to human 07. Homologous ß subunits from differ-
ent mammalian species are generally 92-98% identical in
this region (Erle et al ., 1991b) . Distinct ß subunits are much
less closely related in all known cases : for example, human
07 is only 61% identical to its closest known relative, 02,
in this region . Based upon these observations, we have desig-
nated the partial cDNA amplified fromTM cells as mouse
07. The 07 sequence obtained from TK-1 cells is completely
identical to sequences we previously obtained from mouse
WR 2.3 T lymphoma cells and P388D1 macrophage-like
cells (Erle et al ., 1991b) . Human 07 mRNA is also present
in both T cells and macrophage-like cells (Erle et al .,
1991x) .
To identify the 07 subunit protein, we raised an antiserum
against a synthetic peptide modeled after the deduced amino
acid sequence of the carboxyl terminus of human 07 . This
antiserum clearly cross 'reacts with mouse 07, since it im-
munoprecipitates similar complexes from mouse andhuman
lymphocytes (Figs . 1 and 3) . The complex from TK-1 cells
includes proteins of ti150, 120, 80, and 70 kD . We used
EDTA to dissociate the complex and demonstrated that the
07 anti-peptide antiserum recognizes the 120-kD protein .
This protein migrates more slowly under reducing condi-
tions, which is characteristic of integrin ß subunits and pre-
sumably relates to disruption of extensive intrachain disulfide
bonding. The anti-peptide antiserum is apparently specific
for 07 : the most closely related knownß subunit, 02, is 67%
identical to an 18-amino acid portion ofthe peptide, but the
antiserum clearly does not immunoprecipitate 02 (Figs . 1
and 3) . By immunodepleting the TK-1 lysate with antibody
to the a4 subunit (Fig . 2 A), we showed that the other compo-
nents of the 07 complex are intact a4 (150 kD) and cleaved
a4 (80 and 70 kD) . No other a subunits associate with 07
in TK-1 cells .
We also used immunoprecipitation and immunodepletinn
to show that the novel mAb LS722, raised against mesenteric
lymphocytes (Sikorski, E . E ., and E . C. Butcher, manu-
script in preparation), recognizes a4ß7 (Figs . 1 and 2) . mAb
LS722 recognizes the 07 subunit, and not a4, since EDTA
releases the a4 subunit from the antibody-antigen complex
(Fig . 2B) . As expected, mAb LS722 reacts with TK-1 cells,
which express a4ß7 (Fig . 9), but does not react with other
mouse cells that express a4ß1 but nota4ß7 (unpublished ob-
servations) .
Our results indicate that a4ß7 is identical to a4ßP The
a4ßP complex was first identified when TK-1 cells were
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noted to express a4 in the absence of its only previously de-
scribed partner, 01 (Holzmann and Weissman, 1989). The
alternative partner for a4 in TK-1 cells was designated as SP
Our results indicate that 07 is the partner for a4 in these
cells, and we therefore infer that 07 and SP are identical.
We also studied 07 expression on human peripheral blood
T lymphocytes by Northern blotting and immunoprecipita-
tion (Fig. 3) . 07 is expressed late after in vitro T cell activa-
tion. Immunoprecipitation analysis suggests that x407 may
be the major 07-containing integrin expressed on activated
T cells, although we cannot exclude the possibility that other
07-containing integrins may also be expressed on these cells.
In fact, activated cells are weakly positive for HML-1, an an-
tibody believed to recognize a 07-containing integrin (Schie-
ferdecker et al ., 1990, and data not shown). HML-1 antigen
and its putative mouse homolog M290 antigen are appar-
ently different from a4ß7 because TK-1 cells express high
levels ofa4ß7 but express little or no M290 antigen (Fig. 9).
This implies that the M290 antibody is not directed against
the 07 subunit itself. Instead, M290 may recognize an a
subunit other than a4 that associates with 07 in some cells.
We used TK-1 cells to study the function of a4ß7/ce40P
These cells are especially well suited for this purpose be-
cause they do not express detectable amounts of 01-
containing integrins, including a4ß1. Holzmann and Weiss-
man (1989) used Northern blotting and two different antisera
against 01 to demonstrate that TK-1 cells do not express 01.
In experiments reported here, we were unable to detect 01
mRNA with the homology PCR technique and used a third
antiserum to confirm that 01 proteins are not present on TK-
1 cells. We also chose to study TK-1 cellsbecause these cells
have been used previously to study the function of a40P
(Holzmann and Weissman, 1989; Holzmann et al., 1989) .
These studies demonstrated that the adhesion of TK-1 cells
to Peyer's patch high endothelial venules is dependent on
ce40P The nature of the a40P ligand(s) expressed on these
endothelial cells is unclear. We were interested in attempting
to identify well-defined ligands of a4ß7/a40P
Since most known integrins mediate adhesion to one or
more extracellular matrix proteins, we first tested the adhe-
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Figure 9 Analysis ofadhesion
molecule expression on TK-1
cells by flow cytometry. TK-1
cells were incubated for 30
min in the absence (- - -) or
presence ( ) of PMA
(100 ng/ml) and then analyzed
using flow cytometry. mAbs
against a4 (PS/2 and RI-2),
07 (722), LFA-1 (FD441),
VCAM-1 (MIK--1), and the
mAb M290 were used. Back-
ground fluorescence (phyco-
erythrin-labeled goat anti-rat
antibody only) is represented
by the dotted lines.
sion of TK-1 cells to a variety of these proteins. PMA-
stimulated TK-1 cells adhered to intact fibronectin and to the
38-kD tryptic fragment of fibronectin containing the CS-1
region, but not to vitronectin, collagen I or IV, laminin,
fibrinogen, or the 120-kD fragment of fibronectin that con-
tains the RGD region (Figs. 4 and 5 and data not shown).
Binding to fibronectin was specifically inhibited by anti-a4
mAbs and by a soluble CS-1 peptide. Affinity chromatogra-
phy experiments usinga CS-1 peptide and a control peptide
column confirmed that a4ß7 binds to the CS-1 region (Fig.
6). a4ß7 is slowly released from the column even during
washing with a buffer containing a physiological concentra-
tion of salt (lanes 1-12); this indicates that the a4ß7-CS-1
interaction, like many other integrin-ligand interactions, is
of low affinity (Pytela et al., 1987) . Taken together, these
results demonstrate that a4ß7/a401' mediates cell adhesion
to fibronectin by binding to the CS-1 region. o401 is the only
other integrin that has been shown to bind to this region
(Wayner et al ., 1989; Guan and Hynes, 1990; Mould et al.,
1990).
Because of this striking functional similarity between
a4ß l and a4ß7, we wondered whether a4ß7 might also
share other ligands with a4ß1. a4ß1 has been convincingly
demonstrated to mediate lymphocyte adherence to en-
dothelium by binding to the vascular cell adhesion molecule
VCAM-1 (Elices et al., 1990; Carlos et al., 1990) . To deter-
mine whether a4ß7 might have a similar function, we stud-
ied TK-1 cell adhesion to human recombinant soluble
VCAM-1 (Fig. 7). PMA-stimulated TK-1 cells adhered very
efficiently to human VCAM-1 and adhesion was specifically
and completely inhibited by antibodies directed against a4
and VCAM-1. This result strongly suggests that a4ß7 can
mediate adhesion to endothelium by binding to VCAM-1 .
TK-1 cell adhesion to fibronectin and to VCAM-1 was
greatly enhanced by brief PMA stimulation. It has previ-
ously been shown that brief stimulation of T cells with PMA
or other agents results in increased binding activity of several
integrins, including LFA-1, a4ß1, a5ß1, and a6ß1, without
affecting levels of expression of these molecules (Dustin and
Springer, 1989; Shimizu et al ., 1990a) . The effect of PMAstimulation on a4ß7 is similar: binding is increased without
any change in level of surface expression of either a4 or 07
(Fig. 9). The effect of PMA stimulation was apparent within
15 min and maximal at -30 min (data not shown); these ki-
netics are not consistent with new synthesis of a4ß7 or other
proteins. In particular, we demonstrated that brief PMA
stimulation does not induce expression ofa4ßl on TK-1 cells
(Fig. 1). Instead, our data strongly suggest that PMA affects
the function of a4ß7 molecules already present on the cell
surface.
We also investigated the phenomenon of antibody-induced
cell clustering in TK-1 cells. It has previously been shown
that some mAbs directed against the a4 subunit of a4ß1
induce clustering of lymphocytes (see introduction) . We
showed that mAbs directed against either subunit of a4ß7
can induce dramatic TK-1 cell clustering (Table I and Fig.
8). a4ß7-induced clustering, like a4ß1-induced clustering,
is dependent upon the presence of divalent cations and is
VCAM-1 and LEA-1 independent. The anti-ß7 mAb LS722,
like some previously described anti-a4 antibodies (Pulido et
al., 1991), induces cell clustering but has no effect in
fibronectin and VCAM-1 adhesion assays (Figs. 5 and 7) . It
is not yet known how antibodies to a4ß7 and a4ß1 induce
cell clustering. It is intriguing to speculate that the in vitro
clustering phenomenon might reflect a role for a4ß7 in lym-
phocyte-lymphocyte interactions in vivo.
While our datado suggest that a4ß7/a4ßP and A01 share
similar ligands, there are likely to be important differences
between these integrins. The distribution of a4ß7/a4ßP and
A01 is clearly different. Individual lymphoma cell lines
may express either one or both of these integrins (Holzmann
and Weissman, 1989) . Flow cytometry indicates that a4ß1
is poorly represented on mucosa-associated lymphocytes
whereas a4ß7 is highly expressed in mucosal sites (Picker
et al., 1990; and Sikorski, E. E., and E. C. Butcher, manu-
script in preparation) . Expression of these integrins is also
regulated differently. While a4ß1 is easily detectable on
resting T cells, we were able to detect a4ß7 only after T cell
activation. Integrins are known to be involved in signaling,
and it is possible that a4ß7/a4ßP and a4ß1 might transduce
different signals after binding similar ligands. Integrin sig-
naling is believed to involve interaction of the integrin cyto-
plasmic domain with other cytoplasmic elements (see Hynes,
1987; Ruoslahti, 1991). The cytoplasmic domains of human
07 and ßl are only 47% identical and differ most strikingly
because of the presence of five additional amino acids at the
carboxyl terminus of 07 (Erle et al., 1991x) . It remains to
be determined if this difference has functional implications.
While previous work (Holzmann and Weissman, 1989;
Holzmann et al., 1989) suggested that a4ßP might function
as a Peyer's patch lymphocyte homing receptor, our findings
demonstrate that a4ß7/a4ßP recognizes widely distributed
ligands. There are at least two fundamentally different ways
in which these two sets of observations can be reconciled.
First, it is possible that additional, as yet unidentified a4ß7
ligands are expressed only on Peyer's patch HEV. These
ligands might play a more important role than fibronectin
or VCAM-1 in Peyer's patch homing. Second, it may be
that an adhesion molecule other than a4ß7/a4ßPis responsi-
ble for initial specific binding to Peyer's patch HEV, while
a4ß7/a4ßP is responsible for stabilizing this interaction.
The initial binding might involve an as yet unidentified lym-
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phocyte adhesion molecule which recognizes the mucosal
vascular addressin (Berg, 1991) . This model is reminiscent
of the interaction of neutrophils with venular endothelium:
initial adhesion is mediated by members of the selectin fam-
ily ofadhesion molecules, followed by a more durable inter-
action between neutrophil 02 integrins and endothelial cell
ICAMs (Kishimoto et al., 1989; Lawrence and Springer,
1991; Hallmann et al., 1991; von Andrian et al., 1991). The
stabilizing interaction of T cells with Peyer's patch HEV can
apparently be mediated by either a4ß7/a4ßP or by a4ß1
since adherence of TK50 cells, which express only a4ß1,
to Peyer's patch HEV can be inhibited by antibody against
a4 (Holzmann and Weissman, 1989). This suggests that
a4ß7/a4ßP may be only one of multiple adhesion receptors
involved in Peyer's patch homing.
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